TriSalus Life Sciences (TLSI) Capital Expenditures Growth (3y) (2025 - 2026)

TriSalus Life Sciences (TLSI) Capital Expenditures Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Abbott Laboratories 183.95 Bn 176.66 Bn 6.27 Bn 1.64%
2 Stryker 128.80 Bn 125.92 Bn 3.81 Bn 8.49%
3 Medtronic 108.82 Bn 99.60 Bn 6.41 Bn 8.89%
4 Boston Scientific 68.54 Bn 67.08 Bn 3.61 Bn 16.83%
5 Edwards Lifesciences 48.37 Bn 44.70 Bn 1.29 Bn 1.81%
6 Dexcom 28.41 Bn 27.30 Bn 750.30 Mn 0.84%
7 GE HealthCare Technologies 28.33 Bn 26.04 Bn 1.98 Bn 7.57%
8 Smith & Nephew 26.96 Bn 26.38 Bn - -
9 Koninklijke Philips 25.43 Bn 22.31 Bn 2.07 Bn 2.15%
10 TriSalus Life Sciences 224.71 Mn 168.16 Mn 7.67 Mn 172.09%

Historic Data

Download Data
DateValue
Mar 31, 2026 172.09%
Dec 31, 2025 -22.60%